We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$7.72B
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
13.4%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
777
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.66% |
| 3 | Consumer Discretionary | 14.41% |
| 4 | Industrials | 14.14% |
| 5 | Financials | 12.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Franco-Nevada
FNV
$51.3B
| $381K | 0.07% |
+2,672
| New | +$401K |
|
|
EFOR
552
Everforth Inc
EFOR
$1.34B
| $381K | 0.07% |
+5,037
| New | +$362K |
|
553
Belden
BDC
$4.33B
| $380K | 0.07% |
3,977
+1,029
| +35% | +$88.1K |
|
554
Bruker
BRKR
$9.35B
| $380K | 0.07% |
5,142
+789
| +18% | +$60.1K |
|
|
SRCL
555
DELISTED
Stericycle Inc
SRCL
| $378K | 0.07% |
+8,150
| New | +$357K |
|
556
Burford Capital
BUR
$872M
| $378K | 0.07% |
31,005
+40
| +0.1% | +$518 |
|
557
Hilton Grand Vacations
HGV
$2.77B
| $377K | 0.07% |
8,293
+2,447
| +42% | +$109K |
|
558
Middleby
MIDD
$5.08B
| $374K | 0.07% |
+2,532
| New | +$357K |
|
|
DESP
559
DELISTED
Despegar.com
DESP
| $374K | 0.07% |
53,032
+18,212
| +52% | +$112K |
|
560
Owens Corning
OC
$9.79B
| $372K | 0.07% |
+2,850
| New | +$312K |
|
561
Privia Health
PRVA
$2.54B
| $372K | 0.07% |
14,235
+6,286
| +79% | +$166K |
|
562
Atomera
ATOM
$161M
| $372K | 0.07% |
+42,367
| New | +$334K |
|
563
Alignment Healthcare
ALHC
$1.73B
| $372K | 0.07% |
64,615
+18,840
| +41% | +$122K |
|
564
Agnico Eagle Mines
AEM
$101B
| $371K | 0.07% |
+7,429
| New | +$402K |
|
565
Popular Inc
BPOP
$10.3B
| $369K | 0.07% |
+6,095
| New | +$359K |
|
|
NVO
566
Novo Nordisk
NVO
$191B
| $368K | 0.07% |
+4,552
| New | +$372K |
|
567
PACCAR
PCAR
$61.1B
| $368K | 0.07% |
4,401
-1,724
| -28% | -$128K |
|
|
ATYR
568
aTyr Pharma
ATYR
$35.6M
| $368K | 0.07% |
+170,425
| New | +$372K |
|
569
StoneCo
STNE
$2.2B
| $368K | 0.07% |
+28,873
| New | +$360K |
|
570
LiveRamp
RAMP
$2.29B
| $368K | 0.07% |
12,871
-7,130
| -36% | -$177K |
|
|
THR
571
DELISTED
Thermon Group Holdings
THR
| $367K | 0.07% |
+13,805
| New | +$320K |
|
572
Icon
ICLR
$12.7B
| $367K | 0.07% |
1,466
-1,949
| -57% | -$414K |
|
573
Universal Electronics
UEIC
$66.9M
| $366K | 0.07% |
38,048
+18,740
| +97% | +$174K |
|
574
Ryder
R
$9.15B
| $366K | 0.07% |
+4,311
| New | +$355K |
|
|
EA
575
DELISTED
Electronic Arts
EA
| $365K | 0.07% |
2,817
-3,313
| -54% | -$420K |
|
Similar funds
AL
EGM
CGH
CG
NAMA
AAB
AC
EMPI
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.8M of net new capital in Q2 2023, opening 777 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 777 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.